nach oben

Somnologie

Erschienen in:

01.09.2014 | Übersichten

Koronare Herzkrankheit und schlafbezogene Atmungsstörungen

verfasst von: PD Dr. S. Steiner, M. Arzt

Erschienen in: Somnologie | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Epidemiologische Studien und pathophysiologische Erkenntnisse ergeben hinreichende Anhaltspunkte für einen möglicherweise kausalen Zusammenhang zwischen schlafbezogenen Atmungsstörungen und Entstehung bzw. Verlauf der koronaren Herzerkrankung. Untersuchungen zur koronaren Kalklast, zur Endothelfunktion und zum Verlauf nach perkutaner Koronarintervention bzw. nach Myokardinfarkt belegen die Bedeutung schlafbezogener Atmungsstörungen für kardiologische Patienten. Somit kommen der Detektion und Behandlung schlafbezogener Atmungsstörungen eine unmittelbare Bedeutung in der kardiologischen Diagnostik und Therapie, beispielsweise nach perkutaner Koronarintervention oder in der Postinfarkttherapie, zu.

Peker Y, Hedner J, Norum J et al (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166:159–165PubMedCrossRef

Gottlieb D, Yenokyan G, Newman A et al (2010) A prospective study of obstructive sleep apnea and incident coronary herart disease and heart failure: the sleep heart health study. Circulation 122:352–360PubMedCrossRefPubMedCentral

Hayashi M, Fujimoto K, Urushibata K et al (2003) Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest 124:936–941PubMedCrossRef

Sorajja D, Gami A, Somers V et al (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133:927–933PubMedCrossRefPubMedCentral

Turmel J, Series F, Boulet L et al (2007) Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 132:203–209CrossRef

Kent BD, Garvey JF, Ryan S et al (2013) Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study. Eur Respir J 42:1263–1270PubMedCrossRef

Mooe T, Rabben T, Wiklund U et al (1996) Sleep-disordered breathing in men with coronary artery disease. Chest 109:659–663PubMedCrossRef

Andreas S, Schulz R, Werner GS et al (1996) Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 7:541–545PubMedCrossRef

Danzi-Ssoares N, Genta P, Nerbass F et al (2012) Obstructive sleep apnea is common among patients referred for coronary artery bypass grafting and can be diagnosed by portable monitoring. Coron Artery Dis 23:31–38CrossRef

10.

Mooe T, Franklin K, Holmstrom K et al (2001) Sleep-disordered breathing and coronary artery disease: long- term prognosis. Am J Respir Crit Care Med 164:1910–1913PubMedCrossRef

11.

Marin J, Carrizo S, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1045–1053CrossRef

12.

Peker Y, Hedner J, Kraiczi H et al (2000) Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162:81–86PubMedCrossRef

13.

Lee C, Khoo S, Chan M et al (2011) Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med 7:616–621PubMedPubMedCentral

14.

Won C, Chun H, Chandra S et al (2012) Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury. Sleep Breath. doi:10:1007/s11325.012-0653-y

15.

Kuniyoshi F, Garcia-Touchard A, Gami A et al (2008) Day-night variation of acute myocardial infarction ind obstructive sleep apnea. J Am Coll Cardiol 52:343–346PubMedCrossRef

16.

Chami H, Resnick H, Quan S et al (2011) Association of incident cardiovascular disease with progression of sleep disordered breathing. Circulation 123:1280–1286PubMedCrossRefPubMedCentral

17.

Tsukamoto K, Ohara A (2006) Temporal worsening of sleep-disordered breathing in the acute phase of myocardial infarction. Circ J 70:1553–1556PubMedCrossRef

18.

Buchner S, Greimel T, Hetzenecker A et al (2012) Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J 40:1173–1179PubMedCrossRef

19.

Hamilton G, Solin P, Walker A (2008) Coronary blood flow becomes uncoupled from myocardial work during obstructive sleep apnea in the presence of endothelial dysfunction. Sleep 31:809–816PubMedPubMedCentral

20.

Hetzenecker A, Buchner S, Greimel T et al (2012) Cardiac workload in patients with sleep-disordered breathing early after acute myocardial infarction. Chest. doi:10.1378/chest

21.

Arbab-Zadeh A, Levine B, Trost J et al (2009) The effect of acute hypoxemia on coronary arterial dimensions in patients with coronary artery disease. Cardiology 113:149–154PubMedCrossRef

22.

Hanly P, Sasson Z, Zuberi N et al (1993) ST- Segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71:1341–1345PubMedCrossRef

23.

Schäfer H, Koehler U, Ploch T et al (2006) Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnoea and coronary artery disease. Chest 11:387–393

24.

Gami A, Svatikova A, Wolk R et al (2004) Cardiac troponin T in obstructive sleep apnea. Chest 125:2097–2100PubMedCrossRef

25.

Tan C, Chow W, Lam J et al (2006) HDL Dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382PubMedCrossRef

26.

Trzepizur W, Le Vaillant M, Meslier N et al (2013) Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143:1584–1589PubMedCrossRef

27.

Robinson G, Pepperell C, Segal H et al (2004) Circulating cardiovascular risk factors in obstructive sleep apnea: data from randomised controlled trials. Thorax 59:777–782PubMedCrossRefPubMedCentral

28.

Borgel J, Sanner B, Bittlinsky A et al (2006) Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 27:121–127PubMedCrossRef

29.

Meslier N, Gagnadoux F, Giraud P et al (2003) Impaired Glucose-insulin metabolism in males with obstructive sleep apnea syndrome. Eur Respir J 22:156–160PubMedCrossRef

30.

Ip M, Lam B, Ng M et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676PubMedCrossRef

31.

Grote L, Hedner J, Peter J (2000) Sleep- related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 18:679–685PubMedCrossRef

32.

Grunstein R (2001) Obstructive sleep apnea as a risk factor for arterial hypertension. J Sleep Res 4(Suppl 1):166–170CrossRef

33.

Kiselak J, Clark M, Pera V et al (1993) The association between hypertension and sleep apnea in obese patients. Chest 104:775–780PubMedCrossRef

34.

Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 320:479–482PubMedCrossRefPubMedCentral

35.

Milleron O, Pilliere R, Foucher A et al (2004) Benefits of obstructive sleep apnea treatment in coronary artery disease: a long term follow-up study. Eur Heart J 25:728–734PubMedCrossRef

36.

Martinez D, Klein C, Rahmeier L et al (2012) Sleep apnea is a strong predictor for coronary heart disease than traditional risk factors. Sleep Breath 16:695–701PubMedCrossRef

37.

Schulz R, Mahmoudi S, Hattar K et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:570

38.

Lavie L (2003) Obstructive sleep apnea syndrome- an oxidative stress disorder. Sleep Med Rev 7:35–51PubMedCrossRef

39.

Schulz R (2005) The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 25:780–782PubMedCrossRef

40.

Shamsuzzaman ASM, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464PubMedCrossRef

41.

Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134PubMedCrossRef

42.

Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939PubMedCrossRef

43.

Steiner S, Jax T, Evers S et al (2005) Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104:92–96PubMedCrossRef

44.

Ohga E, Nagase T, Tomita T et al (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10–14PubMed

45.

Cassar A, Morgenthaler T, Lennon R et al (2008) Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervetion. J Am Coll Cardiol 50:1310–1314CrossRef

46.

Steiner S, Schueller P, Hennersdorf M et al (2008) Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res 9:1–7CrossRef

47.

Hayashi M, Fujimoto K, Urushibata K et al (2005) Nocturnal oxygen desaturation as a predictive risk factor for coronary restenosis after coronary intervention – serial quantitative coronary angiography study. Circ J 69:1320–1326PubMedCrossRef

48.

Hrynkewicz-Szymanska A, Szymanski F, Fillipack K et al (2010) Can obstructive sleep apnea be a cause of in-stent thrombosis? Sleep Breath 15:607–609CrossRef

49.

Nakashima H, Katayama T, Takagi C et al (2007) Obstructive sleep apnea inhibits the recoverry of left ventricular function in patients with acute myocardial infarction. Eur Heart J 27:2317–2322CrossRef

50.

Buchner S, Satzl A, Debl K et al (2014) Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocadial infarction. Eur Heart J 35:192–199PubMedCrossRef

51.

Nakashima H, Muto S, Amenomori K et al (2011) Impact of obstructive sleep apnea on myocardial tissue perfusion oin patients with ST-Segment elevation myocardial infarction. Circ J 75:890–896PubMedCrossRef

52.

Kuniyoshi F, Singh P, Gami A et al (2011) Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction. Chest 140:62–67CrossRef

53.

Karatzis M, Ikonomidis I, Vamvakou G et al (2006) Long-Term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol 98(11):1424–1428PubMedCrossRef

54.

Correia L, Souza A, Garcia G et al (2012) Obstructive sleep apnea affects hospital outcome of patients with non-ST-elevation acute coronary syndromes. Sleep 35:1241–1245PubMedPubMedCentral

55.

Bloch KE, Schoch OD, Zhang JN, Russi EW (1999) German version of the Epworth sleepiness scale. Respiration 66:440–447PubMedCrossRef

56.

Steiner S, Schueller P, Schulze V et al (2010) Occurence of coronary collateral vessels in patients with sleep apnea and totoal coronary artery occlusion. Chest 137:516–520PubMedCrossRef

57.

Shah N, Redline S, Yaggi H et al (2013) Obstructive sleep apnea and acute myocardial infarction severity: ischemic preconditioning? Sleep Breath 17:819–826PubMedCrossRef

58.

Konecny T, Kuniyoshi F, Orban M et al (2010) Under-Diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 56:742–743PubMedCrossRefPubMedCentral

59.

Netzer N, Stoohs R, Netzer C et al (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485–491PubMedCrossRef

60.

Dorkova Z, Petrasova D, Molcanyiova A et al (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134:686–692PubMedCrossRef

61.

Buchner N, Sanner B, Borgel J et al (2007) Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 176:1274–1280PubMedCrossRef

62.

Peled N, Abindar E, Pillar G et al (1999) Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive airway pressure treatment. J Am Coll Cardiol 34:1744–1749PubMedCrossRef

63.

Garcia-Rio F, Alonso-Fernandez A, Armada E et al (2013) CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol 168:1328–1335PubMedCrossRef

64.

Sampol G, Rodes G, Romero O et al (2007) Adherence to nCPAP in patients with coronary artery disease and sleep apnea without sleepiness. Respir Med 101:461–466PubMedCrossRef

65.

Weinreich G, Wessendorf TE, Erdmann T et al (2013) Association of obstructive sleep apnoea with subclinical coronary atherosclerosis. Atherosclerosis 231:191–197PubMedCrossRef

Titel: Koronare Herzkrankheit und schlafbezogene Atmungsstörungen
verfasst von: PD Dr. S. Steiner
M. Arzt
Publikationsdatum: 01.09.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Somnologie / Ausgabe 3/2014
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI: https://doi.org/10.1007/s11818-014-0676-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Koronare Herzkrankheit und schlafbezogene Atmungsstörungen

Zusammenfassung

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Die Rolle gastrointestinaler Peptidhormone für REM-Schlaf-Verhaltensstörung und Morbus Parkinson

Genetische Aspekte der REM-Schlaf-Verhaltensstörung

Mitteilungen der DGSM

Tiermodelle der REM-Schlaf-Verhaltensstörung

REM-Schlafverhaltensstörung

REM-Schlafverhaltensstörung – Status quo der diagnostischen Methoden und Bedeutung der Diagnose im Zusammenhang mit neurodegenerativen Erkrankungen

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie